Checklists
Published in full, on the page, with no form in front of them. If a checklist is useful it should be usable — the newsletter is a separate, genuine opt-in.
Researchers, laboratory managers and procurement
The specific requests that separate a supplier with a real documentation chain from one with a marketing asset — and how to read what comes back.
25 checks across 6 sections
Anyone reviewing supplier documentation
Every field on a certificate of analysis, what it establishes, and what its absence means — in the order that determines whether the rest of the document can be read at all.
17 checks across 4 sections
Anyone reading a peptide COA
One page: what each method establishes, what it does not, and which question you are actually asking.
8 checks across 3 sections
Operators
Documentation, claims, payments and working capital — the constraints that determine whether a peptide operation survives. Not a storefront recipe.
6 checks across 3 sections
Procurement and researchers
Compare laboratories on stated methods, sample requirements, reporting policy and accreditation claims — without turning silence into a yes.
6 checks across 2 sections
Editors, operators, researchers
Primary sources Therapept actually uses: FDA compounding pages, Drugs@FDA, PubChem, WADA, ISO/ICH. Not a vendor roundup.
6 checks across 2 sections
Operators considering a branded site
What has to be true of claims, documentation and payments before a peptide storefront is worth building. Not a theme picker.
4 checks across 2 sections
Newsletter
Changes to peptide regulation, testing practice and supplier documentation — sent when there is something specific to report, not on a schedule.
